Reckitt is expanding its over-the-counter analgesics range with the launch of Nurofen Zavance Mini Liquid Capsules – the brand’s smallest liquid capsule to date.
The new format responds to a common consumer concern: difficulty swallowing pain relief products. Recent research shows that 57 percent of consumers under 30 struggle to swallow pain relief products, and 36 percent prefer the smallest tablet or capsule available.
At 20 percent smaller than standard Nurofen Zavance Liquid Capsules, the new mini format offers the same effective pain relief as Nurofen Zavance Liquid Capsules in a more compact size. It is designed to support those who find it challenging to swallow larger capsules.
“We know that ease of use is a key driver of purchase decisions in the pain relief category,” said Dan Amza, Head of Category, Trade Strategy & Activation at Reckitt.
“With Nurofen Zavance Mini Liquid Capsules, we’re supporting a clear consumer need while giving retailers a compelling opportunity to grow the category. The smaller liquid capsule size, combined with portability, makes it an easy recommendation for shoppers seeking fast, effective pain relief.”
This launch strengthens Nurofen’s fast relief portfolio, broadening the range of formats available to consumers.
While Nurofen Zavance Tablets and Caplets are absorbed up to twice as fast as standard Nurofen, and Nurofen Quickzorb delivers rapid relief in a tablet format, Nurofen Zavance Liquid Capsules are known for “unleashing the speed of liquid” – using a liquid form of ibuprofen in a soft gelatin shell that dissolves quickly in the stomach.
Nurofen Zavance Liquid Capsules are for the temporary relief from pain and inflammation. Always read the label and follow the directions for use. Incorrect use could be harmful. Do not use if you have a stomach ulcer. If symptoms persist see your healthcare professional. Reckitt, Auckland. TAPS NP23149
Read more in the latest issue here
